Disposition of14C-labelled endotelon in humans

Summary: In order to study the disposition of ENDOTELON in humans, this compound was labelled withl4C by photosynthesis. ENDOTELON consists of a complex of procyanidolic oligomers extracted from the seeds of a variety of vine cultivated in the Bordeaux wine-growing region, and is prescribed for the treatment of chronic venous insufficiency and retinal lesions. Considering the difficulty in labelling the various constituents of the product, the labelling procedure was based on providing radioactive C02 to the plant. After isolation and purification, 150 mg of active material (50 μCf) was administered orally to six healthy volunteers. Radioactivity was measured in the blood over time until 72 and 120 hours in the same subjects after drug administration. Urinary and faecal elimination was measured for a period of 167 hours. Urinary elimination of the radioactive compounds represented 12 to 27% of the administered dose and faecal elimination represented 47 to 75% depending on the subject. The radioactivity of thel4C02 eliminated in the breath was also measured, and represented around 8% of the total radioactivity for the 72-hour period after administration. Although the disposition of ENDOTELON is based on the total radioactivity measured over time, this technique allows the evaluation of the elimination rate of the product and its metabolites from the human bod

Experimental Test of the Numerical Renormalization Group Theory for Inelastic Scattering from Magnetic Impurities

We present measurements of the phase coherence time \tauphi in quasi one-dimensional Au/Fe Kondo wires and compare the temperature dependence of \tauphi with a recent theory of inelastic scattering from magnetic impurities (Phys. Rev. Lett. 93, 107204 (2004)). A very good agreement is obtained for temperatures down to 0.2 $T_K$. Below the Kondo temperature $T_K$, the inverse of the phase coherence time varies linearly with temperature over almost one decade in temperature.Comment: 5 pages, 3 figure

Effect of Magnetic Impurities on Energy Exchange between Electrons

In order to probe quantitatively the effect of Kondo impurities on energy exchange between electrons in metals, we have compared measurements on two silver wires with dilute magnetic impurities (manganese) introduced in one of them. The measurement of the temperature dependence of the electron phase coherence time on the wires provides an independent determination of the impurity concentration. Quantitative agreement on the energy exchange rate is found with a theory by G\"{o}ppert et al. that accounts for Kondo scattering of electrons on spin-1/2 impurities.Comment: 4 page

Quantum Hall resistance standards from graphene grown by chemical vapor deposition on silicon carbide

Replacing GaAs by graphene to realize more practical quantum Hall resistance standards (QHRS), accurate to within $10^{-9}$ in relative value, but operating at lower magnetic fields than 10 T, is an ongoing goal in metrology. To date, the required accuracy has been reported, only few times, in graphene grown on SiC by sublimation of Si, under higher magnetic fields. Here, we report on a device made of graphene grown by chemical vapour deposition on SiC which demonstrates such accuracies of the Hall resistance from 10 T up to 19 T at 1.4 K. This is explained by a quantum Hall effect with low dissipation, resulting from strongly localized bulk states at the magnetic length scale, over a wide magnetic field range. Our results show that graphene-based QHRS can replace their GaAs counterparts by operating in as-convenient cryomagnetic conditions, but over an extended magnetic field range. They rely on a promising hybrid and scalable growth method and a fabrication process achieving low-electron density devices.Comment: 12 pages, 8 figure

The study of doping market: how to produce intelligence from Internet forums

Despite the predominant role played by Internet in the distribution of doping substances, little is currently known about the online offer of doping products. Therefore, the study focuses on the detection of doping substances and suppliers discussed in Internet forums. It aims at having a comprehensive understanding of products and sellers to lead an operational monitoring of the online doping market. Thirteen community forums on the Internet were investigated and one million topics were extracted with source code scrappers. Then, a semantic analysis was conducted with a semi-automatic process to classify the relevant words according to doping matters. Additionally, the ranking of doping products, active substances and suppliers in regards to the number of contributors to the forums were established and analyzed over time. Finally, promotion methods of suppliers were evaluated. The results show that anabolic androgenic steroids, used to enhance body image and performance, are the most discussed type of products. A temporal analysis illustrates the stability of the most popular products as well as the emergence of new products such as peptides (e.g. CJC-1295). 327 suppliers were detected, mostly with dedicated websites or direct sales by e-mail as selling methods. Globally, the implemented methodology shows its ability to detect products and suppliers as well as to follow their temporal trends. The intelligence will serve the definition of online monitoring strategies (e.g. the selection of appropriate keywords). Additionally, it also allows the adjustment of customs inspection strategies and anti-doping analysis by monitoring the popular and emerging substances

Review of health-related quality of life data in multiple myeloma patients treated with novel agents

In multiple myeloma (MM), health-related quality of life (HRQoL) data is becoming increasingly important, owing to improved survival outcomes and the impact of treatment-related toxicity on HRQoL. Researchers are more frequently including HRQoL assessments in clinical trials, but analysis and reporting of this data has not been consistent. A systematic literature review assessed the effect of novel agents (thalidomide, bortezomib and lenalidomide) on HRQoL in MM patients, and evaluated the subsequent reporting of these HRQoL results. A relatively small body of literature addresses HRQoL data in MM patients treated with novel MM therapeutic agents: 9 manuscripts and 15 conference proceedings. The literature demonstrates the complementary value of HRQoL when assessing clinical response, progression, overall survival and toxicity. However, weaknesses and inconsistencies in analysis and presentation of HRQoL data were observed, often complicating interpretation of the impact of treatment on HRQoL in MM. Further evaluation of HRQoL in MM patients treated with novel agents is required in larger cohorts, and ideally in head-to-head comparative studies. Additionally, the development of standardised MM-specific best practice guidelines in HRQoL data collection and analysis is recommended. These would ensure that future data are more useful in guiding predictive models and clinical decisions